Picks of the quarter Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Picks of the quarter

ATHR 5.855

-2.4%

Dec 9 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bonefish who wrote (18688)	1/14/2016 9:58:49 AM
From: Glenn Petersen	of 20435

KaloBios's stock crashes after Nasdaq delisting allows trading to finally resume By Tomi Kilgore MarketWatch Published: Jan 13, 2016 9:53 a.m. ET KaloBios Pharmaceuticals Inc.'s stock kbioq plunged 92% in morning trade Wednesday, as its delisting from the Nasdaq exchange has allowed it to resume trade for the first time in a month. The bankrupt drug maker's stock, which is now trading over-the-counter, was halted on Dec. 17 after majority owner Martin Shkreli was arrested on fraud charges. The stock last changed hands at $2, which was 3.4% below where it closed on Nov. 18 at $2.07, before the company announced that Shkreli had taken control of the company. The stock then soared to a closing high of $39.50 on Nov. 23 before pulling back. marketwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next